Serological and molecular detection of hepatitis C virus in Amran governorate, Yemen

也门阿姆兰省丙型肝炎病毒的血清学和分子检测

阅读:1

Abstract

BACKGROUND: Hepatitis C virus (HCV) is a blood-borne virus that causes acute or chronic hepatitis, depending on its severity, and its development leads to cirrhosis or hepatocellular carcinoma. This study aimed to detect HCV using the serological and molecular techniques among blood donors and clinical visitors in Amran governorate, Yemen. METHODS: A total of 800 blood specimens were collected from blood donors (500 specimens) and clinical visitors (300 specimens). Blood specimens were screened for HCV using an immunochromatographic technique (ICT) and the enzyme-linked immunosorbent assay (ELISA), and the final positive cases for HCV were confirmed by nested polymerase chain reaction (nPCR). RESULTS: Out of 800 specimens, only 21 (2.6%) were reported as positive for HCV by molecular analysis. According to diagnostic techniques, 18 (2.3%), 22 (2.7%), and 21 (2.6%), respectively, of specimens were reported as positive for HCV by ICT, ELISA, and PCR techniques. Moreover, a higher rate of HCV was found among participants aged 21-30 years (4.3%), females (2.5%), urban residents (2.7%), single individuals (3.1%), and uneducated individuals (6.1%). In addition, the proportion of HCV was significantly higher among participants with a family history of HCV infection (11.6%), previous surgery (30.8%), no blood transfusion (2.9%), prior cupping (9.1%), and perinatal injury (4.6%). CONCLUSION: This finding indicates that the prevalence rate of HCV infection in the study area is high. To protect the general public from the spread of HCV infection, it is essential to develop a public health approach including surveillance and monitoring, strengthening infrastructure, training healthcare workers in early detection and treatment of cases, and increasing public awareness.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。